Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03695081Not ApplicableCompleted

Patient Pathway Pharmacist - Optimal Drug-related Care

Role: collaborator

NCT04573491Not ApplicableCompleted

Implementation of Pharmacogenetic Testing in Hospital Wards

Role: lead

NCT03691324Not ApplicableCompleted

Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study

Role: collaborator

NCT02336113Not ApplicableUnknown

Oslo Pharmacist Intervention Study - Effect on Readmissions

Role: collaborator

NCT03173690Not ApplicableUnknown

Medicines Reconciliation at an Intensive Care Unit

Role: collaborator

All 5 trials loaded